This company has been marked as potentially delisted and may not be actively trading. NYSE:CMD Cantel Medical (CMD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Cantel Medical Stock (NYSE:CMD) 30 days 90 days 365 days Advanced Chart Get Cantel Medical alerts:Sign Up Key Stats Today's Range$80.37▼$80.3750-Day Range$80.37▼$88.7952-Week Range$39.40▼$89.76VolumeN/AAverage Volume626,604 shsMarket Capitalization$3.58 billionP/E Ratio69.28Dividend Yield0.26%Price TargetN/AConsensus RatingN/A Company Overview Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey. Read More Cantel Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks28th Percentile Overall ScoreCMD MarketRank™: Cantel Medical scored higher than 28% of companies evaluated by MarketBeat, and ranked 816th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Cantel Medical. Earnings and Valuation0.6 / 5Proj. Earnings Growth6.11% Earnings GrowthEarnings for Cantel Medical are expected to grow by 6.11% in the coming year, from $2.62 to $2.78 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cantel Medical is 69.28, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.91.Price to Earnings Ratio vs. SectorThe P/E ratio of Cantel Medical is 69.28, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.21.Price to Earnings Growth RatioCantel Medical has a PEG Ratio of 1.63. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCantel Medical has a P/B Ratio of 4.64. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CMD. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldCantel Medical has a dividend yield of 0.26%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCantel Medical does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Cantel Medical is 12.73%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Cantel Medical will have a dividend payout ratio of 7.55% next year. This indicates that Cantel Medical will be able to sustain or increase its dividend.Read more about Cantel Medical's dividend. Sustainability and ESG4.1 / 5Environmental Score-1.60 Short InterestThere is no current short interest data available for CMD. News and Social Media0.6 / 5News SentimentN/A Search Interest1 people have searched for CMD on MarketBeat in the last 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cantel Medical insiders have not sold or bought any company stock.Percentage Held by Insiders10.70% of the stock of Cantel Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions84.13% of the stock of Cantel Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cantel Medical's insider trading history. Receive CMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cantel Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address CMD Stock News HeadlinesCMD solicits govt support for Plateau hospitalAugust 3, 2024 | msn.comNAUTH CMD hails minister, seeks more collaborations on healthcareJuly 31, 2024 | msn.comAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and searches — are feeding the next wave of AI innovation. Big Tech is harvesting it. Mode Mobile is giving it back to you. They are creating a user-powered data economy that shares the upside, and +50M users have already generated +$325M in earnings. This isn't a theory… Mode’s 32,481% revenue growth from 2019-2022 landed them the #1 spot on Deloitte’s 2023 list of fastest growing companies in software, and they’ve secured the Nasdaq ticker $MODE ahead of a potential IPO. The offering could close any moment now. AI breakthroughs are everywhere, but these models need your data to survive. Invest in the company that allows you to share in the profits from yours.July 29 at 2:00 AM | Mode Mobile (Ad)Shoebury Cantel Medical homes site tree felling startingFebruary 14, 2024 | msn.comCantel Medical's New CEO Jorgen B. Hansen to 'Close a Couple of Deals' in 'Near Future'May 7, 2023 | thestreet.comWhat’s Driving The Growth For STERIS Stock?October 7, 2022 | forbes.comMagellan Health, Inc. NewsAugust 2, 2022 | thestreet.comHere Is What Donald Trump's Policies May Mean for Medical Equipment CompaniesJuly 19, 2022 | thestreet.comSee More Headlines CMD Stock Analysis - Frequently Asked Questions How were Cantel Medical's earnings last quarter? Cantel Medical Corp. (NYSE:CMD) announced its earnings results on Monday, March, 8th. The company reported $0.79 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.29. Cantel Medical's revenue was up 1.9% compared to the same quarter last year. What other stocks do shareholders of Cantel Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cantel Medical investors own include Meta Platforms (META), NVIDIA (NVDA), M&T Bank (MTB), Johnson & Johnson (JNJ), Lam Research (LRCX), Pfizer (PFE) and Exxon Mobil (XOM). Company Calendar Last Earnings3/08/2021Today7/29/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNYSE:CMD CIK19446 Webwww.cantelmedical.com Phone973-890-7220FaxN/AEmployees3,669Year FoundedN/AProfitability EPS (Trailing Twelve Months)$1.65 Trailing P/E Ratio69.28 Forward P/E Ratio30.68 P/E Growth1.63Net Income$13.71 million Net Margins4.72% Pretax MarginN/A Return on Equity12.13% Return on Assets4.45% Debt Debt-to-Equity Ratio1.16 Current Ratio2.72 Quick Ratio2.00 Sales & Book Value Annual Sales$1.02 billion Price / Sales3.52 Cash Flow$3.38 per share Price / Cash Flow23.78 Book Value$17.31 per share Price / Book4.64Miscellaneous Outstanding Shares44,513,000Free FloatN/AMarket Cap$3.58 billion OptionableOptionable Beta1.55 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NYSE:CMD) was last updated on 7/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cantel Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cantel Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.